comparemela.com
Home
Live Updates
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimers in the EU and UK : comparemela.com
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK
/PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC, ASX: MXC, OTC:MGCLF), a European based bio-pharma company specializing in the production and development of...
Related Keywords
Australia
,
United States
,
Denmark
,
Netherlands
,
United Kingdom
,
Brazil
,
Luxembourg
,
Italy
,
Perth
,
Western Australia
,
Ireland
,
Spain
,
France
,
London
,
City Of
,
Tavistock
,
Devon
,
America
,
Turner Pope
,
Andy Thacker James Pope
,
Roby Zomer
,
Charles Vivian Tim Pearson
,
David Lim
,
Gareth Williams
,
Instagram
,
Linkedin
,
Twitter
,
Science International
,
Ireland Medical Cannabis Access Programme
,
Pharmaceuticals Ltd
,
University Of Notre Dame
,
Facebook
,
Sciensus Rare
,
Drug Resistant Epilepsy
,
Market Authorization
,
Early Access Programmes
,
Named Patient
,
Managing Director
,
Western Europe
,
Investigational Medicinal Product
,
Medical Cannabis Access
,
Notre Dame
,
North America
,
Kingdom Broker
,
Mgc Pharmaceuticals Ltd
,
comparemela.com © 2020. All Rights Reserved.